Skip to main content

Advertisement

SpringerLink
Log in

Deciphering the Role of WNT Signaling in Metabolic Syndrome–Linked Alzheimer’s Disease

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

It has been well established in recent research that there is a strong correlation between metabolic syndrome (MetS) and Alzheimer’s disease (AD). However, the knowledge of exact mechanistic behind this association remains elusive. It has been reported in recent studies that inflammation and hypercoagulation are pivotal to the pathophysiology of MetS-induced AD. It is rather captivating that aberrant Wnt signaling pathway has been found to be implicated in each of the four conditions, i.e., inflammation, hypercoagulation, MetS, and AD. Deregulation of Wnt signaling has been affiliated with numerous brain pathologies, including Alzheimer’s disease and insulin resistance. In recent past, it has been proposed that the Wnt pathway can act as a central integrator of metabolic signals from peripheral organs to the brain, which would constitute a unique character for Wnt signaling in glucose metabolism. The review educates in what way distinct components of Wnt signaling impact effector mediators of inflammation, hypercoagulation, which in turn decelerate the progression of AD in MetS. Furthermore, components of Wnt signaling, namely, Wnt3a and GSK-3β, interlink MetS and AD. The review opines a contemporary hypothesis that Wnt signaling is implicated in the pathogenesis of MetS-induced AD via impacting inflammation and coagulation. Hence, targeting Wnt signaling could be a novel approach to halt the progression of MetS-linked AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Husain I, Akhtar M, Madaan T, Vohora D, Abdin MZ, Islamuddin M, Najmi AK (2018) Tannins enriched fraction of Emblica officinalis fruits alleviates high-salt and cholesterol diet-induced cognitive impairment in rats via Nrf2–ARE pathway. Front Pharmacol 9:23

    PubMed  PubMed Central  Google Scholar 

  2. Motamedi S, Karimi I, Jafari F (2017) The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): kill two birds with one stone. Metab Brain Dis 32:651–665. https://doi.org/10.1007/s11011-017-9997-0

    Article  CAS  PubMed  Google Scholar 

  3. Pugazhenthi S (2017) Metabolic syndrome and the cellular phase of Alzheimer’s disease. Prog Mol Biol Transl Sci 146:243–258. https://doi.org/10.1016/bs.pmbts.2016.12.016

    Article  CAS  PubMed  Google Scholar 

  4. Suidan GL, Singh PK, Patel-Hett S, Chen ZL, Volfson D, Yamamoto-Imoto H, Norris EH, Bell RD et al (2018) Abnormal clotting of the intrinsic/contact pathway in Alzheimer disease patients is related to cognitive ability. Blood Adv 2(9):954–963

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Cortes-Canteli M, Mattei L, Richards AT, Norris EH, Strickland S (2015) Fibrin deposited in the Alzheimer’s disease brain promotes neuronal degeneration. Neurobiol Aging 36(2):608–617. https://doi.org/10.1016/j.neurobiolaging.2014.10.030

    Article  CAS  PubMed  Google Scholar 

  6. Ma Q, Jiang L, Mao J, Xu W, Huang M (2018) Vildagliptin prevents cognitive deficits and neuronal apoptosis in a rat model of Alzheimer’s disease. Mol Med Rep 17:4113–4119. https://doi.org/10.3892/mmr.2017.8289

    Article  CAS  PubMed  Google Scholar 

  7. Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131:417–430

    CAS  PubMed  Google Scholar 

  8. Abhishek RA, Ansari SA, Das K, Prasad R, Bhattacharya A (2017) Coagulation factor VIIa–mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression. J Biol Chem 292(33):13688–13701. https://doi.org/10.1074/jbc.M116.764670

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Abou Ziki MD, Mani A (2018) The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome. Nutr Res. https://doi.org/10.1016/j.nutres.2018.06.009

    PubMed  Google Scholar 

  10. Prestwich TC, MacDougald OA (2007) Wnt/beta-catenin signaling in adipogenesis and metabolism. Curr Opin Cell Biol 19:612–617

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Ciani L, Salinas PC (2005) WNTs in the vertebrate nervous system: from patterning to neuronal connectivity. Nat Rev Neurosci 6(5):351–362

    CAS  PubMed  Google Scholar 

  12. Tapia-Rojas C, Inestrosa NC (2018) Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer’s disease. Neural Regen Res 13(10):1705–1710. https://doi.org/10.4103/1673-5374.238606

    Article  PubMed  PubMed Central  Google Scholar 

  13. Hartz AMS, Bauer B, Soldner ELB, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U et al (2012) Amyloid-훽 contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43(2):514–523

    CAS  PubMed  Google Scholar 

  14. Ying Z, Nan-qu H, Fei Y, Hai J, Shaoyu Z, Jing-shan S, Feng J (2018) Diabetes mellitus and Alzheimer’s disease: GSK-3β as a potential link. Behav Brain Res. https://doi.org/10.1016/j.bbr.2017.11.015

    CAS  PubMed  Google Scholar 

  15. Zhang W, Xin L, Lu Y (2017) Integrative analysis to identify common genetic markers of metabolic syndrome, dementia, and diabetes. Med Sci Monit 23:5885–5891. Published 2017. https://doi.org/10.12659/MSM.905521

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jayaraman A, Pike CJ (2014) Alzheimer’s disease and type 2 diabetes: multiple mechanisms contribute to interactions. Curr Diab Rep 14(4):476

    PubMed  PubMed Central  Google Scholar 

  17. Dijk V, Gertjan et al (2015) Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration. Front Neurosci 9:173. https://doi.org/10.3389/fnins.2015.00173

  18. Contreras DL, Carvajal K, Rios DT, Bocanegra DF, Peña VC (2014) Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer’s disease? Oxidative Med Cell Longev. 497802. https://doi.org/10.1155/2014/497802

    Google Scholar 

  19. Gutierrez ER, Arenas GM, Trevino S, Espinosa B, Chavez R, Rojas K et al (2017) Alzheimer’s disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration. Synapse. 71:e21990. https://doi.org/10.1002/syn.21990

    Article  CAS  Google Scholar 

  20. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell. 137:47–59

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer’s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164

    PubMed  PubMed Central  Google Scholar 

  22. Won JC, Park CY, Oh SW, Lee ES, Youn BS, Kim MS (2014) Plasma clusterin (ApoJ) levels are associated with adiposity and systemic inflammation. PLoS One 9(7):e103351

    PubMed  PubMed Central  Google Scholar 

  23. Seo JA, Kang MC, Ciaraldi TP, Kim SS, Park KS, Choe C, Hwang WM, Lim DM et al (2018) Circulating ApoJ is closely associated with insulin resistance in human subjects. Metabolism. 78:155–166. https://doi.org/10.1016/j.metabol.2017.09.014

    Article  CAS  PubMed  Google Scholar 

  24. Pinto D, Clevers H (2005) Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 306:357–363

    CAS  PubMed  Google Scholar 

  25. Sharma RP et al (1976) Effect of the Wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. Dev Biol 48:461–465

    CAS  PubMed  Google Scholar 

  26. Niehrs C (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13:767–779

    CAS  PubMed  Google Scholar 

  27. Jeong WJ, Ro EJ, Kang-Yell Choi KY (2018) Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway. npj Precision Oncol 2:5. https://doi.org/10.1038/s41698-018-0049-y

    Article  CAS  Google Scholar 

  28. MacDonald BT, Tamai K, He X (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17:9–26

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023–1026

    CAS  PubMed  Google Scholar 

  30. Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M, Niehrs C (2007) Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316:1619–1622

    CAS  PubMed  Google Scholar 

  31. Zeng X, Huang H, Tamai K, Zhang X, Harada Y, Yokota C, Almeida K, Wang J et al (2008) Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions. Development 135:367–375

    CAS  PubMed  Google Scholar 

  32. Metcalfe C, Mendoza-Topaz C, Mieszczanek J, Bienz M (2010) Stability elements in the LRP6 cytoplasmic tail confer efficient signalling upon DIX-dependent polymerization. J Cell Sci 123:1588–1599

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L, Sakamoto D, Caothien RH et al (2001) Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta-catenin signaling is activated in human colon tumors. Proc Natl Acad Sci U S A 98:14973–14978

    CAS  PubMed  PubMed Central  Google Scholar 

  34. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B et al (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512

    CAS  PubMed  Google Scholar 

  35. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422–426

    CAS  PubMed  Google Scholar 

  36. Willert J, Epping M, Pollack JR, Brown PO, Nusse R (2002) A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev Biol 2:8

    PubMed  PubMed Central  Google Scholar 

  37. Hendrickx M, Leyns L (2008) Non-conventional Frizzled ligands and Wnt receptors. Dev Growth Different 50:229–243

    CAS  Google Scholar 

  38. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321–325

    CAS  PubMed  Google Scholar 

  39. Li L, Mao J, Sun L, Liu W, Wu D (2002) Second cysteine-rich domain of Dickkopf-2 activates canonical Wnt signaling pathway via LRP-6 independently of dishevelled. J Biol Chem 277:5977–5981

    CAS  PubMed  Google Scholar 

  40. Mao B, Niehrs C (2003) Kremen2 modulates Dickkopf2 activity during Wnt/lRP6 signaling. Gene 302:179–183

    CAS  PubMed  Google Scholar 

  41. Ma B, Hottiger MO (2016) Crosstalk between Wnt/β-catenin and NF-κB signaling pathway during inflammation. Front Immunol 7:378. https://doi.org/10.3389/fimmu.2016.00378

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Ma B, van Blitterswijk CA, Karperien M (2012) A Wnt/beta-catenin negative feed-back loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum 64(8):2589–2600. https://doi.org/10.1002/art.34425

    Article  CAS  PubMed  Google Scholar 

  43. Sun J, Hobert ME, Duan Y, Rao AS, He TC, Chang EB, Madara JL (2005) Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 289(1):G129–G137. https://doi.org/10.1152/ajpgi.00515.2004

    Article  CAS  PubMed  Google Scholar 

  44. Duan Y, Liao AP, Kuppireddi S, Ye Z, Ciancio MJ, Sun J (2007) Beta-catenin activity negatively regulates bacteria-induced inflammation. Lab Investig 87(6):613–624. https://doi.org/10.1038/labinvest.3700545

    Article  CAS  PubMed  Google Scholar 

  45. Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W, Xing L (2012) Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Mol Immunol 52(1):38–49. https://doi.org/10.1016/j.molimm.2012.04.005

    Article  CAS  PubMed  Google Scholar 

  46. Kim SJ, Lim JY, Lee JN, Choe SK, Kim YI, Song SR, Cho M, So HS et al (2014) Activation of beta-catenin by inhibitors of glycogen synthase kinase-3 ameliorates cisplatin-induced cytotoxicity and pro-inflammatory cytokine expression in HEI-OC1 cells. Toxicology 320:74–82. https://doi.org/10.1016/j.tox.2014.01.013

    Article  CAS  PubMed  Google Scholar 

  47. Hao HP, Wen LB, Li JR, Wang Y, Ni B, Wang R, Wang X, Sun MX et al (2015) LiCl inhibits PRRSV infection by enhancing Wnt/beta-catenin pathway and suppressing inflammatory responses. Antivir Res 117:99–109. https://doi.org/10.1016/j.antiviral.2015.02.010

    Article  CAS  PubMed  Google Scholar 

  48. Ke B, Shen XD, Kamo N, Ji H, Yue S, Gao F, Busuttil RW, Kupiec-Weglinski JW (2013) Beta-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury. Hepatology 57(3):1203–1214. https://doi.org/10.1002/hep.26100

    Article  CAS  PubMed  Google Scholar 

  49. Manicassamy S, Reizis B, Ravindran R, Nakaya H, Salazar-Gonzalez RM, Wang YC, Pulendran B (2010) Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329(5993):849–853. https://doi.org/10.1126/science.1188510

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, Yamagoe S, Colnot S et al (2012) Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice. J Clin Invest 122(2):586–599. https://doi.org/10.1172/JCI43937

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Martin M, Rehani K, Jope RS, Michalek SM (2005) Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 6(8):777–784. https://doi.org/10.1038/ni1221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Levi M, van der Poll T, Buller HR (2004) Bidirectional relation between inflammation and coagulation. Circulation 109:2698–2704

    PubMed  Google Scholar 

  53. Levi M, Cate H (1999) Disseminated intravascular coagulation. N Engl J Med 341:586–592

    CAS  PubMed  Google Scholar 

  54. Shu F, Kobayashi H, Fukudome K, Tsuneyoshi N, Kimoto M, Terao T (2000) Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner. FEBS Lett 477:208–212

    CAS  Google Scholar 

  55. Bajzar L, Nesheim ME, Tracy PB (1996) The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent. Blood 88:2093–2100

    CAS  PubMed  Google Scholar 

  56. Raaphorst J, Groeneveld AB, Bossink AW, Hack CE (2001) Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients. Thromb Haemost 86:543–549

    CAS  PubMed  Google Scholar 

  57. White B, Schmidt M, Murphy C, Livingstone W, O’Toole D, Lawler M, O’Neill L, Kelleher D et al (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kB and tumour necrosis factor alpha1 production in the THP-1 monocytic cell line. Br J Haematol 110:130–134

    CAS  PubMed  Google Scholar 

  58. Toltl LJ, Beaudin S, Liaw PC, the Canadian Critical Care Translational Biology Group (2008) Activated protein C up-regulates IL-10 and inhibits tissue factor in blood monocytes. J Immunol 181:2165–2173

    CAS  PubMed  Google Scholar 

  59. Brueckmann M, Hoffmann U, de Rossi L, Weiler HM, Liebe V, Lang S, Kaden JJ, Borggrefe M et al (2004) Activated protein C inhibits the release of macrophage inflamatory protein-1-alpha from THP-1 cells and from human monocytes. Cytokine 26:106–113

    CAS  PubMed  Google Scholar 

  60. Feistritzer C, Mosheimer BA, Sturn DH, Riewald M, Patsch JR, Wiedermann CJ (2006) Endothelial protein C receptor-dependent inhibition of migration of human lymphocytes by protein C involves epidermal growth factor receptor. J Immunol 176:1019–1025

    CAS  PubMed  Google Scholar 

  61. Bernard GR, Vincent JL, Laterre PF, LaRosa S, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE et al (2001) Efficacy and safety of recombinant human activated protein c for severe sepsis. N Engl J Med 344:699–709

    CAS  PubMed  Google Scholar 

  62. Taylor FB, Chang A, Esmon CT et al (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79:918–925

    CAS  PubMed  PubMed Central  Google Scholar 

  63. Brueckmann M, Hoffmann U, Dvortsak E et al (2004) Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Inflamm Res 53:528–533

    CAS  PubMed  Google Scholar 

  64. Nick JA, Coldren CD, Geraci MW, Poch KR, Fouty BW, O’Brien J, Gruber M, Zarini S et al (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104:3878–3885

    CAS  PubMed  Google Scholar 

  65. Pereira C, Schaer DJ, Bachli EB (2008) Wnt5A/CaMKII signalling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10. Arterioscler Thromb Vasc Biol 28:504–510

    CAS  PubMed  Google Scholar 

  66. Kopelman P (2000) Obesity as a medical problem. Nature 404:635–643

    CAS  PubMed  Google Scholar 

  67. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald O (2000) Inhibition of adipogenesis by Wnt signaling. Science 289:950–953

    CAS  PubMed  Google Scholar 

  68. Christodoulides C, Lagathu C, Sethi JK, Vidal-Puig A (2009) Adipogenesis and WNT signalling. Trends Endocrinol Metab 20:16–24

    CAS  PubMed  Google Scholar 

  69. Moon RT, Bowerman B, Boutros M, Perrimon N (2002) The promise and perils of Wnt signaling through beta-catenin. Science 296:1644–1646

    CAS  PubMed  Google Scholar 

  70. Choi OM, Cho Y-H, Choi S, Lee S-H, Seo SH, Kim H-Y et al (2014) The small molecule indirubin-30-oxime activates Wnt/b-catenin signaling and inhibits adipocyte differentiation and obesity. Int J Obes 38:1044–1052. https://doi.org/10.1038/ijo.2013.209

    Article  CAS  Google Scholar 

  71. Kaneto H, Matsuoka TA, Nakatani Y, Kawamori D, Miyatsuka T, Matsuhisa M et al (2005) Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. J Mol Med (Berlin, Germany) 83:429–439

    CAS  Google Scholar 

  72. Grimes CA, Jope RS (2001) CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78:1219–1232

    CAS  PubMed  PubMed Central  Google Scholar 

  73. Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxer LM, Heasley LE, Reusch JEB (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J Biol Chem 275:10761–10766

    CAS  PubMed  Google Scholar 

  74. Tanioka T, Tamura Y, Fukaya M, Shinozaki S, Mao J, Kim M, Shimizu N, Kitamura T et al (2011) Inducible nitric-oxide synthase and nitric oxide donor decrease insulin receptor substrate-2 protein expression by promoting proteasome-dependent degradation in pancreatic betacells: involvement of glycogen synthase kinase-3beta. J Biol Chem 286:29388–29396

    CAS  PubMed  PubMed Central  Google Scholar 

  75. Gagliardino JJ, Del Zotto H, Massa L, Flores LE, Borelli MI (2003) Pancreatic duodenal homeobox-1 and islet neogenesis-associated protein: a possible combined marker of activateable pancreatic cell precursors. J Endocrinol 177:249–259

    CAS  PubMed  Google Scholar 

  76. Brownlee M (2003) A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest 112:1788–1790

    CAS  PubMed  PubMed Central  Google Scholar 

  77. Liu Y, Tanabe K, Baronnier D, Patel S, Woodgett J, Cras-Meneur C et al (2010) Conditional ablation of Gsk-3beta in islet beta cells results in expanded mass and resistance to fat feeding-induced diabetes in mice. Diabetologia. 53:2600–2610

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Guo YF, Xiong DH, Shen H, Zhao LJ, Xiao P, Guo Y, Wang W, Yang TL et al (2006) Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study. J Med Genet 43:798–803

    CAS  PubMed  PubMed Central  Google Scholar 

  79. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, Carew KS, Mane S et al (2007) LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science 315:1278–1282

    CAS  PubMed  PubMed Central  Google Scholar 

  80. Singh R, Smith E, Fathzadeh M, Liu W, Go GW, Subrahmanyan L, Faramarzi S, McKenna W et al (2013) Rare nonconservative LRP6 mutations are associated with metabolic syndrome. Hum Mutat 34:1221–1225

    CAS  PubMed  PubMed Central  Google Scholar 

  81. Singh R, De Aguiar RB, Naik S et al (2013) LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans. Cell Metab 17:197–209

    CAS  PubMed  PubMed Central  Google Scholar 

  82. Elghazi L, Gould AP, Weiss AJ, Barker DJ, Callaghan J, Opland D, Myers M, Cras-Méneur C et al (2012) Importance of b-catenin in glucose and energy homeostasis. Sci Rep 2:693

    PubMed  PubMed Central  Google Scholar 

  83. Fujino T, Asaba H, Kang MJ, Ikeda Y, Sone H, Takada S, Kim DH, Ioka RX et al (2003) Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 100:229–234

    CAS  PubMed  Google Scholar 

  84. Liu W, Singh R, Choi CS, Lee HY, Keramati AR, Samuel VT, Lifton RP, Shulman GI et al (2012) Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure. J Biol Chem 287:7213–7223

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Liu W, Mani S, Davis NR, Sarrafzadegan N, Kavathas PB, Mani A (2008) Mutation in EGFP domain of LDL receptor-related protein 6 impairs cellular LDL clearance. Circ Res 103:1280–1288

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Ye ZJ, Go GW, Singh R, Liu W, Keramati AR, Mani A (2012) LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake. J Biol Chem 287:1335–1344

    CAS  PubMed  Google Scholar 

  87. Go GW, Srivastava R, Hernandez-Ono A, Gang G, Smith SB, Booth CJ, Ginsberg HN, Mani A (2014) The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. Cell Metab 19:209–220

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Xu G, Emmons R, Hernández-Saavedra D, Kriska A, Pan YX, Chen H (2017) Regulation of gene expression of Wnt signaling pathway by dietary high fat and effects on colon epithelia of male mice. Nutrition 31(1)

  89. Husain I, Khan S, Khan S, Madaan T, Kumar S, Najmi AK (2019 Apr) Unfolding the pleiotropic facades of rosuvastatin in therapeutic intervention of myriads of neurodegenerative disorders. Clin Exp Pharmacol Physiol 46(4):283–291

    CAS  PubMed  Google Scholar 

  90. Bu’ee L, Troquier L, Burnouf S et al (2010) From tau phosphorylation to tau aggregation: what about neuronal death? Biochem Soc Trans 38(4):967–972

    Google Scholar 

  91. Mattson MP (2004) Pathways towards and away from Alzheimer’s disease. Nature 430(7000):631–639

    CAS  PubMed  PubMed Central  Google Scholar 

  92. Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC (2004) Wnt-3a overcomes b-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297:186–196

    CAS  PubMed  Google Scholar 

  93. Vargas JY, Fuenzalida M, Inestrosa NC (2014) In vivo activation of Wnt signalling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer’s disease model. J Neurosci 34:2191–2202

    CAS  PubMed  PubMed Central  Google Scholar 

  94. Cerpa W, Toledo EM, Varela-Nallar L et al (2009) The role of Wnt signalling in neuroprotection. Drug News Perspect 22:579–591

    CAS  PubMed  Google Scholar 

  95. Quintanilla RA, Muñoz FJ, Metcalfe MJ, Hitschfeld M, Olivares G, Godoy JA et al (2005) Trolox and 17beta-estradiol protect against amyloid beta-peptide neurotoxicity by a mechanism that involves modulation of the Wnt signalling pathway. J Biol Chem 280:11615–11625. https://doi.org/10.1074/jbc.M411936200

    Article  CAS  PubMed  Google Scholar 

  96. Silva-Alvarez C, Arrázola MS, Godoy JA, Ordenes D, Inestrosa NC (2013) Canonical Wnt signalling protects hippocampal neurons from A beta oligomers: role of non-canonical Wnt-5a/Ca(2+) in mitochondrial dynamics. Front Cell Neurosci 7:97. https://doi.org/10.3389/fncel.2013.00097

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Arrazola MS, Varela-Nallar L, Colombres M, Toledo EM, Cruzat F, Pavez L et al (2009) Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. J Cell Physiol 221:658–667

    CAS  PubMed  Google Scholar 

  98. Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11:77–86

    CAS  PubMed  Google Scholar 

  99. Varela-Nallar L, Inestrosa NC (2013) Wnt signaling in the regulation of adult hippocampal neurogenesis. Front Cell Neurosci 7:100

    CAS  PubMed  PubMed Central  Google Scholar 

  100. Inestrosa NC, Varela-Nallar L (2014) Wnt signalling in the nervous system and in Alzheimer’s disease. J Mol Cell Biol 6:64–74. https://doi.org/10.1093/jmcb/mjt051

    Article  PubMed  Google Scholar 

  101. Oliva CA, Inestrosa NC (2015) A novel function for Wnt signalling modulating neuronal firing activity and the temporal structure of spontaneous oscillation in the entorhinal-hippocampal circuit. Exp Neurol 269:43–55

    CAS  PubMed  Google Scholar 

  102. De Ferrari GV, Chacon MA, Barria MI et al (2003) Activation of Wnt signalling rescues neurodegeneration and behavioral impairments induced by b-amyloid fibrils. Mol Psychiatry 8:195–208

    PubMed  Google Scholar 

  103. Vargas JY, Fuenzalida M, Inestrosa NC (2014) In vivo activation of Wnt signaling pathway enhances cognitive function of adult mice and reverses cognitive deficits in an Alzheimer’s disease model. J Neurosci 34(6):2191–2202

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Husain I, Zameer S, Madaan T, Minhaj A, Ahmad W, Iqubaal A, Ali A, Najmi AK (2019) Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review. Metab Brain Dis 8:1–9

    Google Scholar 

  105. Rosi MC, Luccarini I, Grossi C, Fiorentini A, Spillantini MG, Prisco A, Scali C, Gianfriddo M et al (2010) Increased dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J Neurochem 112(6):1539–1551

    CAS  PubMed  Google Scholar 

  106. Killick R, Ribe EM, Al-Shawi R, Malik B, Hooper C, Fernandes C et al (2014) Clusterin regulates beta-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Mol Psychiatry 19:88–98. https://doi.org/10.1038/mp.2012.163

    Article  CAS  PubMed  Google Scholar 

  107. Purro SA, Dickins EM, Salinas PC (2012) The secreted Wnt antagonist dickkopf-1 is required for amyloid 훽-mediated synaptic loss. J Neurosci 32(10):3492–3498

    CAS  PubMed  PubMed Central  Google Scholar 

  108. Chacon MA, Varela-Nallar L, Inestrosa NC (2008) Frizzled-1 is involved in the neuroprotective effect of Wnt3a against Ab oligomers. J Cell Physiol 217:215–227

    CAS  PubMed  Google Scholar 

  109. Wan W, Chen H, Li Y (2014) The potential mechanisms of Abeta-receptor for advanced glycation end-products interaction disrupting tight junctions of the blood-brain barrier in Alzheimer’s disease. Int J Neurosci 124(2):75–81

    CAS  PubMed  Google Scholar 

  110. Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I (2012) Abeta1−42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurin signaling. J Neurosci 32(26):8845–8854

    CAS  PubMed  PubMed Central  Google Scholar 

  111. Mendoza J, Sekiya M, Taniguchi T, Iijima KM, Wang R, Ando K (2013) Global analysis of phosphorylation of tau by the checkpoint kinases Chk1 and Chk2 in vitro. J Proteome Res 12(6):2654–2665

    CAS  PubMed  PubMed Central  Google Scholar 

  112. Folwell J, Cowan CM, Ubhi KK, Shiabh H, Newman TA, Shepherd D, Mudher A (2010) A훽 exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer’s disease. Exp Neurol 223(2):401–409

    CAS  PubMed  Google Scholar 

  113. Alvarez AR, Godoy JA, Mullendorff K, Olivares GH, Bronfman M, Inestrosa NC (2004) Wnt-3a overcomes 훽-amyloid toxicity in rat hippocampal neurons. Exp Cell Res 297(1):186–196

    CAS  PubMed  Google Scholar 

  114. Maguschak KA, Ressler KJ (2012) A role for WNT/beta-catenin signaling in the neural mechanisms of behavior. J NeuroImmune Pharmacol 7(4):763–773

    PubMed  PubMed Central  Google Scholar 

  115. Shruster A, Eldar-Finkelman H, Melamed E, Offen D (2011) Wnt signaling pathway overcomes the disruption of neuronal differentiation of neural progenitor cells induced by oligomeric amyloid 훽-peptide. J Neurochem 116(4):522–529

    CAS  PubMed  Google Scholar 

  116. Cisternas P, Salazar P, Silva-Álvarez C, Barros L (2016) F, Inestrosa NC. Activation of Wnt signaling in cortical neurons enhances glucose utilization through glycolysis. J Biol Chem 291(50):25950–25964

    CAS  PubMed  PubMed Central  Google Scholar 

  117. Schinner S (2009) Wnt-signalling and the metabolic syndrome. Horm Metab Res 41:159–163

    CAS  PubMed  Google Scholar 

  118. Liesa M, Shirihai OS (2013) Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure. Cell Metab 17:491–506

    CAS  PubMed  PubMed Central  Google Scholar 

  119. Brown AM (2004) Brain glycogen re-awakened. J Neurochem 89:537–552

    CAS  PubMed  Google Scholar 

  120. Saez I, Duran J, Sinadinos C, Beltran A, Yanes O, Tevy MF, Martínez-Pons C, Milán M et al (2014) Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia. J Cereb Blood Flow Metab 34:945–955

    CAS  PubMed  PubMed Central  Google Scholar 

  121. Vilchez D, Ros S, Cifuentes D, Pujadas L, Vallès J, García-Fojeda B, Criado-García O, Fernández-Sánchez E et al (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10:1407–1413

    CAS  PubMed  Google Scholar 

  122. Solaz-Fuster MC, Gimeño-Alcañiz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, Criado Garcia O et al (2008) Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP activated protein kinase pathway. Hum Mol Genet 17:667–678

    CAS  PubMed  Google Scholar 

  123. Cohen P, Goedert M (2004) GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov 3:479–487

    CAS  PubMed  Google Scholar 

  124. Cadigan KM (2012) TCFs and Wnt/b-catenin signaling: more than one way ot throw the switch. Transcriptional Switches during Development. Curr Top Dev Biol 98:1–34

    CAS  PubMed  Google Scholar 

  125. Godoy JA, Arrázola MS, Ordenes D, Silva-Alvarez C, Braidy N, Inestrosa NC (2014) Wnt-5a ligand modulates mitochondrial fission-fusion in rat hippocampal neurons. J Biol Chem 289:36179–36193

    CAS  PubMed  PubMed Central  Google Scholar 

  126. Chen EY, DeRan MT, Ignatius MS, Grandinetti KB, Clagg R, McCarthy KM et al (2014) Glycogen synthase kinase 3 inhibitors induce the canonical WNT/beta-catenin pathway to suppress growth and self-renewal in embryonal rhabdomyosarcoma. Proc Natl Acad Sci U S A 111:5349–5354

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, Taif University, Taif, 21974, Saudi Arabia

    Abuzer Ali & Amena Ali

  2. College of Pharmacy, Mohammad Al-Mana College for Health Sciences, Safa, Dammam, 34222, Saudi Arabia

    Wasim Ahmad

  3. College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal, University of Dammam, Dammam, 1982, Saudi Arabia

    Niyaz Ahmad

  4. School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, 110062, India

    Sana Khan & Sheikh Md Nuruddin

  5. Department of Pharmacology, MESCO Institute of Pharmacy, Amroha, Uttar Pradesh, 244221, India

    Ibraheem Husain

Authors
  1. Abuzer Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amena Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wasim Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Niyaz Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sana Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sheikh Md Nuruddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ibraheem Husain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ibraheem Husain.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, A., Ali, A., Ahmad, W. et al. Deciphering the Role of WNT Signaling in Metabolic Syndrome–Linked Alzheimer’s Disease. Mol Neurobiol 57, 302–314 (2020). https://doi.org/10.1007/s12035-019-01700-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-019-01700-y

Keywords

Search

Navigation